文摘
On page 5431, L. De Cola, D. Bonifazi, and co-workers report the fast targeting and cancer cells uptake of nanozeolite/Cetuximab bioconjugates. The effects are depicted on the front cover, which highlights the antibody-dependent and receptor-mediated endocytosis of this luminescent nanomaterial by the cancer cells. This hasty internalization profile can be exploited to reduce the nanomaterial clearance processes occurring in-vivo, which determine unfavourable biodistribution and foster “off-target” activities.